Residency · Residency · Ophthalmology

Angle-Closure Glaucoma: Mechanisms and Management

Overview

Angle-closure glaucoma involves physical obstruction of the trabecular meshwork by the peripheral iris, impeding aqueous outflow and leading to elevated IOP with subsequent optic neuropathy. The condition is more common in East Asian and Inuit populations. Anatomic risk factors include hyperopia (with its short axial length and shallow anterior chamber), older age, female sex, family history, and a thick, anteriorly positioned crystalline lens.

Mechanisms of Angle Closure

1. Pupillary Block (Most Common -- approximately 75% of cases)

Pupillary block is the most common mechanism of angle closure. It results from resistance to aqueous flow at the pupil margin, where the iris and the anterior lens surface come into contact. As aqueous accumulates behind the iris, the peripheral iris bows forward (iris bombe) and mechanically occludes the trabecular meshwork. Pupillary block is maximal at mid-dilation, when the pupil is approximately 3 to 4 mm in diameter -- large enough to maintain some contact with the lens but not so tight as to flatten the iris. Common precipitants include dim lighting, pharmacologic dilation, emotional stress, and prone positioning. The definitive treatment is laser peripheral iridotomy (LPI), which creates an alternative pathway for aqueous to reach the anterior chamber.

2. Plateau Iris

In plateau iris, anteriorly positioned ciliary processes push the peripheral iris root forward against the trabecular meshwork. Unlike pupillary block, the iris configuration is flat or only slightly convex rather than bombe. The critical distinguishing feature is that angle closure persists even after a patent LPI, because the mechanism is not pupillary block but rather direct ciliary body-iris contact. Diagnosis requires UBM, which demonstrates the anteriorly rotated ciliary processes abutting the posterior iris surface. Treatment options include laser peripheral iridoplasty (argon laser applied to the peripheral iris to contract the stroma and pull the iris root away from the angle) and lens extraction.

3. Lens-Induced Mechanisms

The crystalline lens can cause angle closure through two mechanisms. In phacomorphic closure, an intumescent (swollen) cataract pushes the iris forward, shallowing the anterior chamber and closing the angle. In lens subluxation, an anteriorly displaced lens directly narrows the angle. In both situations, lens extraction by cataract surgery is the definitive treatment.

4. Non-Pupillary Block Mechanisms

Several other conditions can produce angle closure. Neovascularization of the angle causes a fibrovascular membrane to form across the trabecular meshwork; as this membrane contracts, it pulls the iris against the meshwork, producing neovascular glaucoma. Intraocular inflammation from uveitis can lead to PAS formation that progressively closes the angle. The ICE syndrome involves abnormal corneal endothelium that migrates and proliferates over the angle structures. Posterior pushing mechanisms include aqueous misdirection (malignant glaucoma), choroidal effusion, intraocular tumors, scleral buckle encircling bands, and retinopathy of prematurity.

Angle-Closure Mechanisms Summary

Clinical Spectrum

Primary Angle-Closure Suspect (PACS)

A primary angle-closure suspect has a narrow angle on gonioscopy, defined as iridotrabecular contact in two or more quadrants, but maintains normal IOP without PAS or optic neuropathy. The risk of progressing to acute angle closure is approximately 0.5% per year. Management is debated between observation with annual monitoring and prophylactic LPI.

Primary Angle Closure (PAC)

Primary angle closure is diagnosed when a narrow angle is accompanied by elevated IOP and/or peripheral anterior synechiae, but no glaucomatous optic neuropathy has yet developed. Management consists of LPI, with IOP-lowering medications added as needed.

Primary Angle-Closure Glaucoma (PACG)

Primary angle-closure glaucoma represents the full disease, with a narrow angle, glaucomatous optic neuropathy, and visual field loss. IOP may be elevated or may be normal -- for example, after spontaneous resolution of an acute episode or in chronic creeping closure where the damage has already occurred. Management includes LPI, IOP-lowering therapy, and potentially surgical intervention.

Acute Angle-Closure Crisis

Presentation

An acute angle-closure crisis presents dramatically with sudden severe eye pain, headache, and nausea or vomiting that can mimic an acute abdomen or migraine. Vision is dramatically reduced, and the patient may report halos around lights. Examination reveals a red eye with conjunctival injection, corneal edema producing a hazy or cloudy cornea, a fixed mid-dilated pupil that is poorly reactive and often vertically oval, and a shallow anterior chamber. IOP is typically 40 to 80 mmHg. Glaukomflecken -- anterior subcapsular lens opacities caused by ischemic necrosis of the lens epithelium -- are a sign of a prior acute attack and are pathognomonic for angle closure.

Emergency Management

Treatment begins immediately with multiple agents administered simultaneously. Topical timolol 0.5% and brimonidine 0.2% reduce aqueous production. Pilocarpine 1 to 2% is given every 15 minutes for two to three doses as a miotic to pull the iris root away from the trabecular meshwork; however, an important caveat is that pilocarpine is ineffective at IOP above approximately 40 mmHg because the iris sphincter muscle is paralyzed by ischemia at these pressures -- it should be started once IOP begins to fall. Prednisolone acetate 1% is administered to reduce the associated inflammation.

For systemic IOP lowering, oral or intravenous acetazolamide 500 mg reduces aqueous production through carbonic anhydrase inhibition. Intravenous mannitol (1 to 2 g/kg) is an osmotic agent that draws water from the vitreous and reduces posterior segment pressure, though it is contraindicated in renal failure and congestive heart failure. The patient should be positioned supine, which allows the lens to fall posteriorly under gravity, deepening the anterior chamber.

The definitive treatment is laser peripheral iridotomy, performed once the cornea clears sufficiently to allow laser delivery, usually within hours to one day after IOP is lowered. If corneal edema prevents adequate visualization, a window can be cleared with topical glycerin, or a Nd:YAG laser can penetrate despite mild edema. Prophylactic LPI should be performed on the fellow eye promptly, as the risk of an acute attack in the untreated fellow eye is 40 to 80% within five to ten years.

Laser Peripheral Iridotomy (LPI)

LPI is performed using a Nd:YAG laser, alone or in combination with argon laser pre-treatment to thin the iris in patients with thick or darkly pigmented irides. The procedure creates a full-thickness hole in the peripheral iris, typically positioned superiorly so it is concealed by the upper eyelid. By creating this opening, aqueous can bypass the pupil-lens contact zone and flow directly from the posterior chamber into the anterior chamber, relieving pupillary block. Nd:YAG settings are typically 3 to 8 mJ per pulse. Complications include transient IOP spike, hyphema, iritis, dysphotopsias (linear light streaks from the iridotomy site), closure of the iridotomy requiring retreatment, and corneal or lens burns. Patency is verified by direct transillumination, gonioscopy showing a deepened angle, and visible retroillumination through the iridotomy.

Laser Peripheral Iridoplasty (Gonioplasty)

Laser peripheral iridoplasty uses argon laser burns placed on the peripheral iris stroma, causing contraction that mechanically pulls the iris root away from the angle. Settings employ a large spot size (200 to 500 micrometers), low power (200 to 400 mW), and long duration (0.3 to 0.5 seconds). This technique is used for plateau iris configuration and as a temporizing measure during acute attacks when corneal edema prevents LPI. It is not a definitive treatment for pupillary block.

EAGLE Study and Lens Extraction

EAGLE Trial

The EAGLE trial (Effectiveness of Early Lens Extraction for the Treatment of Primary Angle-Closure Glaucoma) was a randomized controlled trial comparing clear lens extraction by phacoemulsification with IOL implantation to LPI in patients with PAC or PACG. At three years, lens extraction proved superior to LPI in IOP control, need for additional medications and secondary surgeries, quality of life measures, and cost-effectiveness. These results support early lens extraction -- even when the lens is still clear -- as a first-line treatment for PAC and PACG. However, controversy remains regarding the surgical risk in relatively healthy eyes, adoption in resource-limited settings, and applicability to PACS (which was excluded from the trial). While the approach is increasingly adopted, it is not yet universal, as surgeon comfort with operating on clear lenses varies.

Chronic Angle Closure

Chronic angle closure involves progressive, asymptomatic "creeping" closure of the angle with gradual formation of peripheral anterior synechiae. IOP rises gradually without acute symptoms, and the condition is often detected late with significant optic nerve damage already present. It is particularly common in East Asian populations. Management includes LPI (if any pupillary block component exists), IOP-lowering medications, and potentially surgical intervention with trabeculectomy, tube shunt, or lens extraction for IOP control.

Aqueous Misdirection (Malignant Glaucoma / Ciliary Block)

Aqueous misdirection is a condition in which aqueous humor is directed posteriorly into or behind the vitreous rather than flowing forward through the pupil. The entire lens-iris diaphragm is pushed anteriorly, producing angle closure. It typically occurs after intraocular surgery, particularly surgery for angle-closure glaucoma. The hallmark finding is a uniformly shallow or flat anterior chamber with elevated IOP -- this uniform shallowing distinguishes it from suprachoroidal hemorrhage, which produces a choroidal detachment visible on B-scan ultrasonography. Treatment begins with cycloplegia using atropine 1% (which relaxes the ciliary body and tightens the zonules, pulling the lens-iris diaphragm posteriorly), aqueous suppressants, and hypertonic agents. If medical treatment fails, surgical intervention with vitrectomy, lens extraction, and posterior capsulotomy or hyaloidotomy is required.

<image>Anatomical cross-section diagrams showing the four mechanisms of angle closure. Panel A: Pupillary block — aqueous trapped behind the iris due to iris-lens contact, causing iris bombe (forward bowing of the iris) and closure of the angle. The iridotomy site is shown as a treatment creating a bypass for aqueous flow. Panel B: Plateau iris — anteriorly rotated ciliary processes pushing the peripheral iris root against the trabecular meshwork with a flat iris configuration (no bombe). Panel C: Phacomorphic — an intumescent swollen lens pushing the iris-lens diaphragm forward, narrowing the anterior chamber. Panel D: Aqueous misdirection — aqueous flowing posteriorly behind the vitreous face, pushing the entire lens-iris diaphragm forward with a uniformly shallow anterior chamber. Label the key anatomical structures and aqueous flow direction in each panel.</image>

<image>Clinical photograph montage of acute angle-closure crisis. Four panels: (1) External photograph showing a red eye with conjunctival injection, hazy/edematous cornea, and a fixed mid-dilated pupil; (2) Slit lamp image showing corneal edema with microcystic epithelial changes, shallow anterior chamber, and inflammatory flare; (3) Gonioscopy showing a completely closed angle with iris against the trabecular meshwork in all quadrants; (4) Post-treatment: clear cornea after LPI with a patent peripheral iridotomy visible as a dark hole in the peripheral iris, deepened anterior chamber, and round reactive pupil. Show glaukomflecken on the anterior lens capsule as an inset.</image>

<image>EAGLE study summary infographic. Central comparison showing lens extraction versus LPI for PAC/PACG. Left side (lens extraction): lower IOP at 3 years, fewer medications required, fewer additional surgeries, higher quality of life scores, better cost-effectiveness. Right side (LPI): higher residual IOP, more medications needed, more secondary surgeries required. Include a bar graph comparing the key outcomes between groups. Note at the bottom: "EAGLE excluded PACS; results apply to PAC and PACG with clear or cataractous lens."</image>

Key Clinical Pearls

Acute angle closure is an ophthalmic emergency in which delay in treatment can cause permanent optic nerve damage within hours. Pilocarpine is ineffective when IOP exceeds 40 mmHg because ischemia paralyzes the iris sphincter muscle -- IOP must be lowered with other agents before pilocarpine becomes effective. Prophylactic LPI should always be performed on the fellow eye after an acute attack, given the substantial risk (40 to 80%) of bilateral acute closure within five to ten years. The EAGLE study supports early lens extraction over LPI for PAC and PACG, though adoption varies by region and surgeon preference. Plateau iris should be suspected when the angle remains narrow despite a patent LPI, and the diagnosis is confirmed with UBM. Glaukomflecken are pathognomonic for a prior acute angle-closure attack and should be actively sought on slit lamp examination. Aqueous misdirection (malignant glaucoma) typically occurs after intraocular surgery and produces a uniformly shallow anterior chamber, which distinguishes it from suprachoroidal hemorrhage where B-scan reveals a choroidal detachment. In phacomorphic glaucoma, cataract surgery simultaneously treats both the glaucoma and the cataract.

References

• Azuara-Blanco A, et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet. 2016;388(10052):1389-1397.
• Lam DS, et al. Acute primary angle closure: long-term intraocular pressure outcome in Asian eyes. Ophthalmology. 2009;116(7):1243-1250.
• Ritch R. Plateau iris is caused by abnormally positioned ciliary processes. J Glaucoma. 1992;1(1):23-26.
• AAO BCSC Section 10: Glaucoma. 2023-2024.
• AAO Preferred Practice Pattern: Primary Angle Closure Disease. 2020.

Read this lecture as Markdown